Sargent Investment Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,000
Closed -$27.5K 207
2023
Q2
$27.5K Buy
50,000
+15,000
+43% +$289K 0.01% 199
2023
Q1
$56K Buy
+35,000
New +$610K 0.01% 192
2022
Q3
Sell
-87,500
Closed -$134K 193
2022
Q2
$134K Buy
87,500
+37,500
+75% +$773K 0.04% 174
2022
Q1
$190K Buy
+50,000
New +$977K 0.05% 177
2020
Q4
Sell
-20,000
Closed -$19K 190
2020
Q3
$19K Buy
+20,000
New +$467K 0.01% 163

Other funds holding EXEL

Sargent Investment Group's EXEL Position: Q2 2026 in Review

Sargent Investment Group increased its Exelixis (EXEL) stake by 1.7% in Q2 2026, buying an estimated $148K and bringing the position to 182,055 shares worth $9.91M. The position accounts for 1.19% of the portfolio, ranked #23.

Sargent Investment Group first reported a position in EXEL in Q4 2018 and has held it in 31 quarters since. The position peaked at $12.8M in Q3 2020. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Sargent Investment Group held 182,055 shares of Exelixis worth $9.91M as of Q2 2026.
  • Sargent Investment Group bought 3,030 Exelixis shares in Q2 2026, an estimated $148K.
  • Exelixis made up 1.19% of Sargent Investment Group's portfolio in Q2 2026, its #23 holding.
  • Sargent Investment Group first reported a position in Exelixis in Q4 2018 and has held it in 31 quarters since.
  • Sargent Investment Group's Exelixis position peaked at $12.8M in Q3 2020.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.